News

The Department of Health and Human Services’ (HHS)’ Office of the National Coordinator (ONC) published an interim final rule today delaying several key compliance deadlines in the ONC 21st Century Cures Act final rule – including that of the information blocking provisions, which were slated to b

This quarter, the U.S. announced new sanctions and trade restrictions on China in response to its perceived intrusions on Hong Kong’s autonomy and reported human rights abuses in Xinjiang.

The Situation: This summer, autonomous vehicle ("AV") stakeholders announced pilot programs for AV transport and shipping routes in Michigan and the Southeast.

The Québec Court of Appeal recently released a decision in Micron Technology Inc. c Hazan, 2020 QCCA 1104, that could have important implications for defendants seeking to have proposed class proceedings in Québec courts stayed in favour of proceedings in other Canadian jurisdictions....

Crowdfunding – a mechanism which connects people in need directly to those who are able to provide support – has completely revolutionised the traditional fundraising landscape. But it can come at a cost if the fundraising is not structured appropriately.

Now that the initial wave of COVID-19 has passed and providers have mastered the telehealth billing requirements, it is time to turn attention to the 2021 Evaluation and Management (E&M) changes and their impact on a provider’s practice.

The COVID-19 pandemic caused state and local governments around the country, including in North Carolina, to order a temporary shutdown of bars, restaurants, and other businesses where social distancing could not be maintained.

Riomet®/metformin HCl - Case Name: Sun Pharm. Indus. Ltd. v. Saptalis Pharms., LLC, No. 18-648-WCB, 2020 WL 5077412 (D. Del. Aug. 6, 2020) (Bryson, J.)... Drug Product and Patent(s)-in-Suit: Riomet® (metformin HCl); U.S. Patent No. 6,890,957 (“the ’957 patent”)......

The United States District Court for the District of Connecticut, applying Connecticut law, has found no coverage under a director and officers liability policy for a claim alleging the fraudulent conveyance of a company because it was “related to” a claim challenging the conveyance made prior to

Pages